{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T08:48:58Z","timestamp":1781945338548,"version":"3.54.5"},"reference-count":32,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jcardioanesthesia.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1053\/j.jvca.2017.07.011","type":"journal-article","created":{"date-parts":[[2017,7,12]],"date-time":"2017-07-12T04:17:34Z","timestamp":1499833054000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery"],"prefix":"10.1053","volume":"32","author":[{"given":"Patrick C.","family":"Harper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathan J.","family":"Brinkman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa A.","family":"Passe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darrell R.","family":"Schroeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sameh M.","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A.","family":"Nuttall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C.","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David W.","family":"Barbara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.jvca.2017.07.011_bib1","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1182\/blood.V76.9.1680.1680","article-title":"Bleeding complications associated with cardiopulmonary bypass","volume":"76","author":"Woodman","year":"1990","journal-title":"Blood"},{"key":"10.1053\/j.jvca.2017.07.011_bib2","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1213\/ANE.0000000000001188","article-title":"Prothrombin complex concentrates for bleeding in the perioperative setting","volume":"122","author":"Ghadimi","year":"2016","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.07.011_bib3","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/CIRCULATIONAHA.108.764308","article-title":"Comprehensive Canadian review of the off-label use of recombinant activated factor VII in cardiac surgery","volume":"118","author":"Karkouti","year":"2008","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.07.011_bib4","first-page":"1320","article-title":"Off-label use of recombinant activated factor VII in intractable haemorrhage after cardiovascular surgery: An observational study of practices in 23 French cardiac centres (2005-7)","volume":"40","author":"Hacquard","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.07.011_bib5","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1177\/1089253214534782","article-title":"A 2014 update on coagulation management for cardiopulmonary bypass","volume":"18","author":"Thiele","year":"2014","journal-title":"Semin Cardiothorac Vasc Anesth"},{"key":"10.1053\/j.jvca.2017.07.011_bib6","unstructured":"Novo Nordisk Inc. Product Information: NovoSeven RT: Coagulation factor VIIa (recombinant). Plainsboro, NJ. 2016."},{"key":"10.1053\/j.jvca.2017.07.011_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00000542-200502000-00006","article-title":"Recombinant coagulation factor VIIa in major liver resection: A randomized, placebo-controlled, double-blind clinical trial","volume":"102","author":"Lodge","year":"2005","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2017.07.011_bib8","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.4065\/79.12.1495","article-title":"Recombinant factor VIIa for rapid reversal of warfarin anticoagulation in acute intracranial hemorrhage","volume":"79","author":"Freeman","year":"2004","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.jvca.2017.07.011_bib9","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa042991","article-title":"Recombinant activated factor VII for acute intracerebral hemorrhage","volume":"352","author":"Mayer","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.07.011_bib10","doi-asserted-by":"crossref","first-page":"884","DOI":"10.7326\/0003-4819-137-11-200212030-00009","article-title":"Reversal of warfarin-induced excessive anticoagulation with recombinant human factor VIIa concentrate","volume":"137","author":"Deveras","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.jvca.2017.07.011_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/01.TA.0000171453.37949.B7","article-title":"Recombinant factor VIIa as adjunctive therapy for bleeding control in severely injured trauma patients: Two parallel randomized, placebo-controlled, double-blind clinical trials","volume":"59","author":"Boffard","year":"2005","journal-title":"J Trauma"},{"key":"10.1053\/j.jvca.2017.07.011_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1001\/jama.295.3.293","article-title":"Thromboembolic adverse events after use of recombinant human coagulation factor VIIa","volume":"295","author":"O'Connell","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.jvca.2017.07.011_bib13","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1053\/j.jvca.2017.07.011_bib14","first-page":"86","article-title":"The Australian and New Zealand Haemostasis Registry: Ten years of data on off-licence use of recombinant activated factor VII","volume":"13","author":"Zatta","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1053\/j.jvca.2017.07.011_bib15","year":"2011","journal-title":"Product information: BEBULIN (factor IX complex), nanofiltered and vapor heated. Westlake Village, CA."},{"key":"10.1053\/j.jvca.2017.07.011_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s13054-015-1172-6","article-title":"Safety and efficacy of prothrombin complex concentrate as first-line treatment in bleeding after cardiac surgery","volume":"20","author":"Cappabianca","year":"2016","journal-title":"Crit Care"},{"key":"10.1053\/j.jvca.2017.07.011_bib17","first-page":"148","article-title":"Emergency reversal of anticoagulation with a three-factor prothrombin complex concentrate in patients with intracranial haemorrhage","volume":"9","author":"Imberti","year":"2011","journal-title":"Blood Transfus"},{"key":"10.1053\/j.jvca.2017.07.011_bib18","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1111\/pan.12007","article-title":"New technologies in pediatric anesthesia","volume":"22","author":"Holtby","year":"2012","journal-title":"Paediatr Anaesth"},{"key":"10.1053\/j.jvca.2017.07.011_bib19","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1093\/bja\/aei244","article-title":"Activated recombinant factor VII after cardiopulmonary bypass reduces allogeneic transfusion in complex non-coronary cardiac surgery: Randomized double-blind placebo-controlled pilot study","volume":"95","author":"Diprose","year":"2005","journal-title":"Br J Anaesth"},{"key":"10.1053\/j.jvca.2017.07.011_bib20","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1097\/01.CCM.0000181527.47749.57","article-title":"Recombinant activated factor VII for refractory bleeding after cardiac surgery\u2014A retrospective analysis of safety and efficacy","volume":"33","author":"von Heymann","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1053\/j.jvca.2017.07.011_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s13019-014-0156-y","article-title":"Combination use of platelets and recombinant activated factor VII for increased hemostasis during acute type a dissection operations","volume":"9","author":"Yan","year":"2014","journal-title":"J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.07.011_bib22","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/j.athoracsur.2012.02.037","article-title":"Intraoperative use of low-dose recombinant activated factor VII during thoracic aortic operations","volume":"93","author":"Andersen","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.07.011_bib23","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1093\/icvts\/ivs224","article-title":"Use of prothrombin complex concentrate for excessive bleeding after cardiac surgery","volume":"15","author":"Arnekian","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1053\/j.jvca.2017.07.011_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/CIRCULATIONAHA.108.834275","article-title":"Safety and efficacy of recombinant activated factor VII: A randomized placebo-controlled trial in the setting of bleeding after cardiac surgery","volume":"120","author":"Gill","year":"2009","journal-title":"Circulation"},{"key":"10.1053\/j.jvca.2017.07.011_bib25","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1097\/ALN.0b013e31823497dd","article-title":"First-line therapy with coagulation factor concentrates combined with point-of-care coagulation testing is associated with decreased allogeneic blood transfusion in cardiovascular surgery: A retrospective, single-center cohort study","volume":"115","author":"Gorlinger","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1053\/j.jvca.2017.07.011_bib26","first-page":"1314","article-title":"Recombinant factor VIIa (NovoSeven RT) use in high risk cardiac surgery","volume":"40","author":"Chapman","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1053\/j.jvca.2017.07.011_bib27","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/j.1423-0410.2010.01339.x","article-title":"Comparison of fresh frozen plasma and prothrombin complex concentrate for the reversal of oral anticoagulants in patients undergoing cardiopulmonary bypass surgery: A randomized study","volume":"99","author":"Demeyere","year":"2010","journal-title":"Vox Sang"},{"key":"10.1053\/j.jvca.2017.07.011_bib28","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.jsha.2016.03.001","article-title":"Recombinant activated factor VII for uncontrolled bleeding postcardiac surgery","volume":"28","author":"Habib","year":"2016","journal-title":"J Saudi Heart Assoc"},{"key":"10.1053\/j.jvca.2017.07.011_bib29","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1213\/ANE.0000000000000689","article-title":"An exploratory cohort study comparing prothrombin complex concentrate and fresh frozen plasma for the treatment of coagulopathy after complex cardiac surgery","volume":"121","author":"Ortmann","year":"2015","journal-title":"Anesth Analg"},{"key":"10.1053\/j.jvca.2017.07.011_bib30","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.athoracsur.2014.04.126","article-title":"Recombinant factor VII is associated with worse survival in complex cardiac surgical patients","volume":"98","author":"Alfirevic","year":"2014","journal-title":"Ann Thorac Surg"},{"key":"10.1053\/j.jvca.2017.07.011_bib31","first-page":"1087","article-title":"Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis","volume":"134","author":"Drake","year":"1989","journal-title":"Am J Pathol"},{"key":"10.1053\/j.jvca.2017.07.011_bib32","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1053\/j.jvca.2013.10.015","article-title":"Successful perioperative management of severe bleeding from undiagnosed acquired factor VIII inhibitors","volume":"29","author":"Barbara","year":"2015","journal-title":"J Cardiothorac Vasc Anesth"}],"container-title":["Journal of Cardiothoracic and Vascular Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077017306560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053077017306560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,12]],"date-time":"2020-10-12T02:23:18Z","timestamp":1602469398000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053077017306560"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S1053077017306560"],"URL":"https:\/\/doi.org\/10.1053\/j.jvca.2017.07.011","relation":{},"ISSN":["1053-0770"],"issn-type":[{"value":"1053-0770","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes Following Three-Factor Inactive Prothrombin Complex Concentrate Versus Recombinant Activated Factor VII Administration During Cardiac Surgery","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiothoracic and Vascular Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.jvca.2017.07.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}